Nuvation Bio Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: Nuvation Bio Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Nuvation Bio Inc - Ordinary Shares - Class A
Rating: 1.88700
Author: Trendlyne DVM scores

about

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

9.44 0.45 (5.01%)

New 52W High today

8.2M

XNYS Volume

XNYS 19 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

5.0 / 100

Technically Bullish

70.5 / 100

1Yr Price target upside is 19%

8 analysts

Nuvation Bio Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Nuvation Bio Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-g...

New 52W High today

SWOT Analysis

Nuvation Bio Inc (Class A) Live Price Chart